F-Prime Capital
Venture capital
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
12Deep-tech portfolio5 active
7Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Affinia Therapeutics
30Co-investorsShare a portfolio company
Portfolio · 12 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Affinia Therapeutics | Biotech | Active | Oct 14, 2025 | $170.1M |
| Beam Therapeutics | Biotech | Active | Mar 26, 2019 | $180.0M |
| ARTBIO | Biotech | Active | — | — |
| Atalanta Therapeutics | Biotech | Active | — | — |
| Xaira Therapeutics | Biotech | Active | — | — |
| Quantum Circuits | Quantum | Acquired | May 2, 2024 | $26.6M |
| Denali Therapeutics | Biotech | Public | Mar 1, 2024 | $499.7M |
| Hinge Health | Digital health | Public | Dec 28, 2023 | $862.3M |
| Vigil Neuroscience | Biotech | Acquired | Aug 29, 2022 | $195.0M |
| Fractyl Health | Medtech | Public | Jan 25, 2022 | $274.5M |
| Prevail Therapeutics | Biotech | Acquired | Mar 14, 2018 | $57.0M |
| Prime Medicine | Biotech | Public | — | — |
Peer ranks
Portfolio size#40
Portfolio exits#26
Raises, 12 months#88
Co-investors#60
Co-investors
- ARCH VentureVenture capital4 shared
- Foresite CapitalVenture capital3 shared
- Alexandria Venture InvestmentsVenture capital2 shared
- Atlas VentureVenture capital2 shared
- Bessemer Venture PartnersVenture capital2 shared
- General CatalystVenture capital2 shared
- OUP (Osage University Partners)Venture capital2 shared
- RA CapitalVenture capital2 shared
- 5AM VenturesVenture capital1 shared
- Andreessen HorowitzVenture capital1 shared
Sectors
- Biotech9
- Digital health1
- Quantum1
- Medtech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.